The novel H1N1 flu pandemic in 2009 underscored weaknesses in methods widely used to diagnose the flu, from frequent false negatives to long wait times for results. Now a four-year, National Institutes of Health-funded study of 146 patients with flu-like symptoms spearheaded by Associate Professor Catherine Klapperich (BME, MSE) has validated a prototype rapid, low-cost, accurate, point-of-care device that promises a better standard of care.
